← Leaderboards
Michelle Ng Gong
Massachusetts General Hospital
$11,453,323
Attributed
$19,088,166
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–20$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$17,895,133 · 9
AHRQ$1,193,033 · 1
By mechanism
U01$8,869,220 · 3
R01$4,267,744 · 2
UH3$3,271,943 · 1
R18$1,193,033 · 1
K23$649,755 · 1
UH2$611,559 · 1
Top collaborators
- Ognjen Gajic10 shared
- Lynne D. Richardson9 shared
- Daniel Stuart Talmor5 shared
- Anne Evelyn Sales2 shared
- Viktor Gamarnik1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jamie S Ostroff$23,039,922
- Nancy A Rigotti$18,154,837
- Rakesh K. Jain$48,476,214
- Michael J Zvolensky$15,215,289
- Angelo Volandes$28,447,159
Others in their field
Top investigators on “Critical Care”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$199,696,645
- Richard A Gibbs · Baylor College Of Medicine$160,914,242
- Abhik Das · Research Triangle Institute$125,490,125
- Michael S. Saag · University Of Alabama At Birmingham$103,023,496
Research focus
Critical CareAcuteIntensive Care UnitsAdult Respiratory Distress SyndromeCritical IllnessPreventionLung InjuryInjuryPreventRandomized Controlled TrialsCaringMedicineHospitalsResearch InfrastructureOrgan FailureMultidisciplinaryClinical TrialsHigh RiskEnrollmentAdultClinical ResearchCostAccident And Emergency DepartmentComputerized Medical Record
Grant awards (40)
TREAT ECARDS: Translating Evidence into Action: Electronic Clinical Decision Support in ARDS$397,809
R18 · FY2020 · HS · contact PI
Einstein PETAL: Clinical Center for the PETAL Network$336,753
U01 · FY2020 · HL · contact PI
Digital Implementation Intervention Trials in Acute Lung Care (DIGITAL-C) Network Planning$419,854
U01 · FY2019 · HL
TREAT ECARDS: Translating Evidence into Action: Electronic Clinical Decision Support in ARDS$397,898
R18 · FY2019 · HS · contact PI
Einstein PETAL: Clinical Center for the PETAL Network$336,753
U01 · FY2019 · HL · contact PI
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E$653,512
UH3 · FY2018 · HL · contact PI
Digital Implementation Intervention Trials in Acute Lung Care (DIGITAL-C) Network Planning$456,989
U01 · FY2018 · HL
TREAT ECARDS: Translating Evidence into Action: Electronic Clinical Decision Support in ARDS$397,326
R18 · FY2018 · HS · contact PI
Einstein PETAL: Clinical Center for the PETAL Network$234,848
U01 · FY2018 · HL · contact PI
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E$167,115
UH3 · FY2018 · HL · contact PI
Einstein PETAL: Clinical Center for the PETAL Network$44,200
U01 · FY2018 · HL · contact PI
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E$820,627
UH3 · FY2017 · HL · contact PI
Einstein PETAL: Clinical Center for the PETAL Network$277,188
U01 · FY2017 · HL · contact PI
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E$821,506
UH3 · FY2016 · HL · contact PI
Einstein PETAL: Clinical Center for the PETAL Network$275,518
U01 · FY2016 · HL · contact PI
Utilizing Innovative Technology To Improve Compliance With Patient Elevation Guidelines â The Impact Of Angulus On Adherence To The Evidence-Based VAP-Prevention Bundle$224,912
R43 · FY2016 · HL
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E$457,591
UH3 · FY2015 · HL · contact PI
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E$351,592
UH3 · FY2015 · HL · contact PI
Einstein PETAL: Clinical Center for the PETAL Network$267,298
U01 · FY2015 · HL · contact PI
Einstein PETAL: Clinical Center for the PETAL Network$8,611
U01 · FY2015 · HL · contact PI
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E$611,559
UH2 · FY2014 · HL · contact PI
Einstein PETAL: Clinical Center for the PETAL Network$144,236
U01 · FY2014 · HL · contact PI
LIPS-A: Lung Injury Prevention Study with Aspirin$2,217,606
U01 · FY2013 · HL
LIPS-A: Lung Injury Prevention Study with Aspirin$2,384,003
U01 · FY2012 · HL
LIPS-A: Lung Injury Prevention Study with Aspirin$1,465,363
U01 · FY2011 · HL
Early Insulin Therapy and Development of ARDS$386,117
R01 · FY2011 · HL · contact PI
Early Insulin Therapy and Development of ARDS$417,188
R01 · FY2010 · HL · contact PI
Surrogate Consent in Research$402,965
R01 · FY2010 · HL · contact PI
Early Insulin Therapy and Development of ARDS$464,295
R01 · FY2009 · HL · contact PI
Surrogate Consent in Research$411,461
R01 · FY2009 · HL · contact PI
Early Insulin Therapy and Development of ARDS$454,040
R01 · FY2008 · HL · contact PI
Surrogate Consent in Research$411,461
R01 · FY2008 · HL · contact PI
Early Insulin Therapy and Development of ARDS$489,176
R01 · FY2007 · HL · contact PI
Surrogate Consent in Research$411,461
R01 · FY2007 · HL · contact PI
Surrogate Consent in Research$419,580
R01 · FY2006 · HL · contact PI
Molecular Epidemiology of ARDS and Septic Shock$129,951
K23 · FY2005 · HL
Molecular Epidemiology of ARDS and Septic Shock$129,951
K23 · FY2004 · HL
Molecular Epidemiology of ARDS and Septic Shock$129,951
K23 · FY2003 · HL
Molecular Epidemiology of ARDS and Septic Shock$129,951
K23 · FY2002 · HL
Molecular Epidemiology of ARDS and Septic Shock$129,951
K23 · FY2001 · HL